Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel E Baker

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Nature Communications|December 5, 2019
Epidemic dynamics of respiratory syncytial virus in current and future climatesRachel E Baker, Ayesha S Mahmud, Caroline E Wagner, et al.
Influenza and Other Respiratory Viruses|December 13, 2023
Modeling the impact of COVID-19 nonpharmaceutical interventions on respiratory syncytial virus transmission in South AfricaSamantha J Bents, Cécile Viboud, Bryan T Grenfell, et al.
Nature Medicine|May 20, 2026
Climate change and infectious diseasesRachel E Baker, Aleksandra R Stamper, Holly A Burrows, et al.
Journal of the Royal Society, Interface|August 29, 2023
Medium-term scenarios of COVID-19 as a function of immune uncertainties and chronic diseaseChadi M Saad-Roy, Sinead E Morris, Rachel E Baker, et al.
Science (New York, N.Y.)|September 22, 2020
Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 yearsChadi M Saad-Roy, Caroline E Wagner, Rachel E Baker, et al.
Nature Reviews. Microbiology|October 14, 2021
Infectious disease in an era of global changeRachel E Baker, Ayesha S Mahmud, Ian F Miller, et al.
Plos Computational Biology|August 5, 2024
Impact of waning immunity against SARS-CoV-2 severity exacerbated by vaccine hesitancyChadi M Saad-Roy, Sinead E Morris, Mike Boots, et al.
Medrxiv : the Preprint Server for Health Sciences|February 10, 2021
Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimesChadi M Saad-Roy, Sinead E Morris, C Jessica E Metcalf, et al.
Science (New York, N.Y.)|March 10, 2021
Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimesChadi M Saad-Roy, Sinead E Morris, C Jessica E Metcalf, et al.
Science (New York, N.Y.)|April 23, 2021
Partial immunity and SARS-CoV-2 mutations-ResponseChadi M Saad-Roy, Sinead E Morris, C Jessica E Metcalf, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Nature Communications|December 5, 2019
Epidemic dynamics of respiratory syncytial virus in current and future climatesRachel E Baker, Ayesha S Mahmud, Caroline E Wagner, et al.
Influenza and Other Respiratory Viruses|December 13, 2023
Modeling the impact of COVID-19 nonpharmaceutical interventions on respiratory syncytial virus transmission in South AfricaSamantha J Bents, Cécile Viboud, Bryan T Grenfell, et al.
Nature Medicine|May 20, 2026
Climate change and infectious diseasesRachel E Baker, Aleksandra R Stamper, Holly A Burrows, et al.
Journal of the Royal Society, Interface|August 29, 2023
Medium-term scenarios of COVID-19 as a function of immune uncertainties and chronic diseaseChadi M Saad-Roy, Sinead E Morris, Rachel E Baker, et al.
Science (New York, N.Y.)|September 22, 2020
Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 yearsChadi M Saad-Roy, Caroline E Wagner, Rachel E Baker, et al.
Nature Reviews. Microbiology|October 14, 2021
Infectious disease in an era of global changeRachel E Baker, Ayesha S Mahmud, Ian F Miller, et al.
Plos Computational Biology|August 5, 2024
Impact of waning immunity against SARS-CoV-2 severity exacerbated by vaccine hesitancyChadi M Saad-Roy, Sinead E Morris, Mike Boots, et al.
Medrxiv : the Preprint Server for Health Sciences|February 10, 2021
Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimesChadi M Saad-Roy, Sinead E Morris, C Jessica E Metcalf, et al.
Science (New York, N.Y.)|March 10, 2021
Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimesChadi M Saad-Roy, Sinead E Morris, C Jessica E Metcalf, et al.
Science (New York, N.Y.)|April 23, 2021
Partial immunity and SARS-CoV-2 mutations-ResponseChadi M Saad-Roy, Sinead E Morris, C Jessica E Metcalf, et al.
Pageof 5